Skip to content
DraconiticResearch
Search Sources API
181,686 studies31 sourcesUpdated 43 min ago
Peer-reviewedCC BYAmerican Heart Journal Plus

Impact of cigarette smoking and cumulative exposure on serum lipid profile: A cross-sectional study

  1. 1Faculty of Pharmacy, University of Kalamoon (UOK), Deir Atiyah, Syria
  2. 2PHD in Department of Microbiology, Hematology and Immunology, Faculty of Pharmacy, University of Kalamoon (UOK), Deir Atiyah, Syria; Corresponding author.

Abstract

Background: Cigarette smoking is a major modifiable risk factor for cardiovascular disease and has been associated with adverse changes in lipid metabolism. However, evidence regarding the relationship between cumulative smoking exposure and lipid profiles in Syrian populations remains limited. Objective: To evaluate the association between cigarette smoking, smoking duration, and cumulative exposure expressed as pack-years with serum lipid parameters among Syrian adults. Methods: A cross-sectional observational study was conducted among 70 adult participants recruited from the laboratory of Al-Nabek Hospital, Deir Atiyah, Syria. Participants included 50 smokers and 20 non-smokers. Serum total cholesterol (TC), triglycerides (TG), low-density lipoprotein cholesterol (LDL-C), and high-density lipoprotein cholesterol (HDL C) were measured using standard enzymatic methods. Smoking duration and cigarettes smoked per day were recorded, and cumulative exposure was estimated using pack-years. Initial comparisons between smokers and non-smokers were performed using independent-samples t -tests. Multivariable linear regression models were subsequently used to examine the association between smoking status and each lipid parameter while adjusting for age and body mass index (BMI). Results: Compared with non-smokers, smokers had higher mean TG (180.58 ± 70.89 vs 128.16 ± 16.00 mg/dL; p = 0.002), LDL-C (101.92 ± 39.10 vs 70.08 ± 10.52 mg/dL; p < 0.001), and TC (186.77 ± 50.10 vs 135.99 ± 12.16 mg/dL; p < 0.001), and lower HDL-C (43.24 ± 4.13 vs 47.54 ± 9.42 mg/dL; p = 0.010). Longer smoking duration was accompanied by progressively higher mean TG, LDL-C, and TC across smoking-duration categories. In multivariable regression adjusted for age and BMI, smoking was independently associated with higher TC (β = 41.47, 95% CI 16.29–66.65; p = 0.002) and LDL-C (β = 24.24, 95% CI 4.60–43.88; p = 0.016), and lower HDL-C (β = −5.51, 95% CI −10.53 to −0.50; p = 0.032). The association with TG was positive but borderline and did not reach conventional statistical significance (β = 35.00, 95% CI −0.41–70.41; p = 0.053). Conclusion: Smoking was associated with an adverse lipid profile characterized by higher TC, LDL-C, and TG and lower HDL C. The associations with TC, LDL-C, and HDL-C remained statistically significant after adjustment for age and BMI. Longer smoking duration was accompanied by less favorable lipid values; however, these findings should be interpreted cautiously because of the exploratory sample size, unequal group sizes, incomplete information on some potential confounders, and the cross-sectional design. The observed pattern across smoking-duration and pack-year categories should not be interpreted as definitive evidence of a causal dose-response relationship.

Related

  1. Associations of Hookah and Cigarette Smoking With In Vitro Fertilization Outcomes: A Cross-Sectional Study.
    Ashraf Moini, Sonia Eskandarion, Atiye Heidaridalfard +2
    Journal of family & reproductive healthPeer-reviewedCC BY-NCFull textObstetrics, gynaecology & paediatricsEurope PMC
  2. Associations of cumulative occupational benzene exposure with genotoxic and immunosenescence-related biomarkers: a cross-sectional study
    Wenqian Xu, Xiaoying Ruan, Lu He +2
    Frontiers in Public HealthPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMCPMC
  3. Interaction Between Cigarette Smoking and PARK16 on Parkinson's Disease.
    Tze Tsung Chong, Jia Dong James Wang, Ebonne Yu-Lin Ng +2
    International journal of molecular sciencesPeer-reviewedCC BYFull textNeurologyEurope PMC
  4. Longitudinal Associations of Cigarette Smoking, Smoking Intensity, and Smoking TrajectoriesWith Emergency Room Utilization Among U.S. Adults
    W. Guo, X. Yan, C. Tatsuoka
    medRxivPreprintCC BYFull textEpidemiology & public healthmedRxiv
  5. Psychosocial correlates of cigarette smoking and e-cigarette use among adults in participating United States jurisdictions: analysis of the 2023 BRFSS
    Ghazi I. Al Jowf
    Frontiers in Public HealthPeer-reviewedCC BY 4.0Full textPhysiologyCrossrefDOAJ
BibTeX
@article{bouzaqli2026impact,
  title = {{Impact of cigarette smoking and cumulative exposure on serum lipid profile: A cross-sectional study}},
  author = {Mustafa Bouzaqli and Reham Ghotani and Nayef Rashid and Rama Al-Shaar and Rama Hussein},
  journal = {American Heart Journal Plus},
  year = {2026},
  month = oct,
  doi = {10.1016/j.ahjo.2026.100969},
  url = {https://doi.org/10.1016/j.ahjo.2026.100969},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Impact of cigarette smoking and cumulative exposure on serum lipid profile: A cross-sectional study
AU  - Mustafa Bouzaqli
AU  - Reham Ghotani
AU  - Nayef Rashid
AU  - Rama Al-Shaar
AU  - Rama Hussein
PY  - 2026
DA  - 2026/10/30
JO  - American Heart Journal Plus
DO  - 10.1016/j.ahjo.2026.100969
UR  - https://doi.org/10.1016/j.ahjo.2026.100969
AB  - Background: Cigarette smoking is a major modifiable risk factor for cardiovascular disease and has been associated with adverse changes in lipid metabolism. However, evidence regarding the relationship between cumulative smoking exposure and lipid profiles in Syrian populations remains limited. Objective: To evaluate the association between cigarette smoking, smoking duration, and cumulative exposure expressed as pack-years with serum lipid parameters among Syrian adults. Methods: A cross-sectional observational study was conducted among 70 adult participants recruited from the laboratory of Al-Nabek Hospital, Deir Atiyah, Syria. Participants included 50 smokers and 20 non-smokers. Serum total cholesterol (TC), triglycerides (TG), low-density lipoprotein cholesterol (LDL-C), and high-density lipoprotein cholesterol (HDL C) were measured using standard enzymatic methods. Smoking duration and cigarettes smoked per day were recorded, and cumulative exposure was estimated using pack-years. Initial comparisons between smokers and non-smokers were performed using independent-samples t -tests. Multivariable linear regression models were subsequently used to examine the association between smoking status and each lipid parameter while adjusting for age and body mass index (BMI). Results: Compared with non-smokers, smokers had higher mean TG (180.58 ± 70.89 vs 128.16 ± 16.00 mg/dL; p = 0.002), LDL-C (101.92 ± 39.10 vs 70.08 ± 10.52 mg/dL; p < 0.001), and TC (186.77 ± 50.10 vs 135.99 ± 12.16 mg/dL; p < 0.001), and lower HDL-C (43.24 ± 4.13 vs 47.54 ± 9.42 mg/dL; p = 0.010). Longer smoking duration was accompanied by progressively higher mean TG, LDL-C, and TC across smoking-duration categories. In multivariable regression adjusted for age and BMI, smoking was independently associated with higher TC (β = 41.47, 95% CI 16.29–66.65; p = 0.002) and LDL-C (β = 24.24, 95% CI 4.60–43.88; p = 0.016), and lower HDL-C (β = −5.51, 95% CI −10.53 to −0.50; p = 0.032). The association with TG was positive but borderline and did not reach conventional statistical significance (β = 35.00, 95% CI −0.41–70.41; p = 0.053). Conclusion: Smoking was associated with an adverse lipid profile characterized by higher TC, LDL-C, and TG and lower HDL C. The associations with TC, LDL-C, and HDL-C remained statistically significant after adjustment for age and BMI. Longer smoking duration was accompanied by less favorable lipid values; however, these findings should be interpreted cautiously because of the exploratory sample size, unequal group sizes, incomplete information on some potential confounders, and the cross-sectional design. The observed pattern across smoking-duration and pack-year categories should not be interpreted as definitive evidence of a causal dose-response relationship.
SN  - 2666-6022
ER  -